These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18335797)

  • 61. Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
    Tricot G; Kern SE; Barlogie B
    J Natl Cancer Inst; 2009 Jul; 101(13):964-6; author reply 966-7. PubMed ID: 19535776
    [No Abstract]   [Full Text] [Related]  

  • 62. Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
    Mehta J
    J Natl Cancer Inst; 2009 Oct; 101(20):1430-1; author reply 1431-3. PubMed ID: 19794130
    [No Abstract]   [Full Text] [Related]  

  • 63. [Clinical implications of bortezomib in frontline treatment of newly-diagnosed multiple myeloma].
    Ohashi K
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):1029-32. PubMed ID: 18633240
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thrombotic thrombocytopenic purpura after autologous peripheral stem cell transplantation.
    Munoz J; Hughes A
    Blood; 2012 Jun; 119(24):5620. PubMed ID: 23509841
    [No Abstract]   [Full Text] [Related]  

  • 65. Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
    Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M
    J Clin Oncol; 2009 Oct; 27(30):5001-7. PubMed ID: 19720903
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 67. High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country.
    Kumar L; Ghosh J; Ganessan P; Gupta A; Hariprasad R; Kochupillai V
    Bone Marrow Transplant; 2009 Mar; 43(6):481-9. PubMed ID: 18978818
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Frontline treatment in elderly patients with multiple myeloma.
    Facon T; San Miguel J; Mateos MV; Hulin C
    Semin Hematol; 2009 Apr; 46(2):133-42. PubMed ID: 19389497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of pegfilgrastim in mobilization of hematopoietic stem cells.
    Kroschinsky F; Hölig K; Ehninger G
    Transfus Apher Sci; 2008 Jun; 38(3):237-44. PubMed ID: 18490197
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE.
    Srikanth M; Davies FE; Wu P; Jenner MW; Ethell ME; Potter MN; Shaw BE; Saso RM; Dines S; Morgan GJ
    Eur J Haematol; 2008 Dec; 81(6):432-6. PubMed ID: 18691254
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiple myeloma involving skin and pulmonary parenchyma after autologous stem cell transplantation.
    Yuan Y; Wieczorek R; Green DL; Cook P; Ballard H; Araten DJ
    J Hematol Oncol; 2009 Nov; 2():48. PubMed ID: 19912647
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical and laboratory features of newly diagnosed multiple myeloma: a retrospective, single-centre analysis.
    Mai YJ; Qi PJ; Xu Y; Zou DH; Wang YF; Zhao YZ; Yang RC; Xiao ZJ; Qiu LG
    Chin Med J (Engl); 2007 Oct; 120(19):1727-9. PubMed ID: 17935680
    [No Abstract]   [Full Text] [Related]  

  • 73. [Successful autologous peripheral blood stem cell transplantation in a case of IgM myeloma].
    Palomera L; Olave T; Domingo JM; Gutiérrez M
    Med Clin (Barc); 2002 Apr; 118(12):478-9. PubMed ID: 11958769
    [No Abstract]   [Full Text] [Related]  

  • 74. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances].
    Testa U
    Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term survival in multiple myeloma.
    Gomez AR
    W V Med J; 1978 Aug; 74(8):181-3. PubMed ID: 98920
    [No Abstract]   [Full Text] [Related]  

  • 76. Uptake of high-dose therapy and peripheral blood stem cell transplantation in myeloma patients <65 years--the role of the myeloma multi-disciplinary team.
    Saravanamuttu K; Byrne JL; Williams C; Das-Gupta EP; Tringham V; Russell NH
    Br J Haematol; 2005 Jul; 130(2):318-9; author reply 319-20. PubMed ID: 16029462
    [No Abstract]   [Full Text] [Related]  

  • 77. [Multiple myeloma. Incidence, clinical expression and management].
    Siegenthaler P; Giger N
    Rev Med Suisse Romande; 1981 Feb; 101(2):83-7. PubMed ID: 7232962
    [No Abstract]   [Full Text] [Related]  

  • 78. Colitis secondary to engraftment syndrome in a patient with autologous peripheral blood stem cell transplant.
    Alkhatib AA; Boynton KK; Badheeb AM
    Dig Dis Sci; 2010 May; 55(5):1500-1. PubMed ID: 19499337
    [No Abstract]   [Full Text] [Related]  

  • 79. Risk of early death in multiple myeloma.
    Kumar S
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):172-4. PubMed ID: 22402425
    [No Abstract]   [Full Text] [Related]  

  • 80. Considerations of the amnion as an autograft and as an allograft in sheep. A preliminary report.
    Trelford JD; Anderson DG; Hanson FW; Mendel V; Sawyer RH
    J Med; 1972; 3(4):231-41. PubMed ID: 4508565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.